Cholera, caused by pathogen V. cholerae, is a potentially fatal infectious disease. V. cholerae uses quorum sensing to communicate with members of its own species and to coordinate a cell density-dependent behavioral response. V. cholerae secretes and detects the quorum sensing molecule CAI-1. When secreted CAI-1 binds the cell surface receptor CqsS, a phosphorylation signal is transmitted into the cell, resulting in altered transcription. This system provides the means for a gene expression response to the detection of a specific pathogen. A hybrid receptor containing the sensory domain of CqsS enables the FDA-approved probiotic Lactococcus lactis to sense the CAI-1 that is secreted by V. cholerae. The circuit downstream of the hybrid receptor is further engineered such that binding of the receptor results in increased expression of a target gene. This target gene can be a colorimetric output for diagnosis, or a variety of antimicrobial agents such as antimicrobial particles (AMPs) or bacteriophage that can inhibit V. cholerae. This system differs from conventional antibiotics in that it serves to both detect and treat disease. It can be used as a preventative measure, a diagnostic tool, and a powerful treatment option.